Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Raghavan

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|December 31, 2015
Predicting Low Trial Accrual Mathematically: Is That the Right Emphasis?Derek Raghavan
JCO Oncology Practice|February 10, 2021
Arrogance or Stupidity? Unsuccessful Approaches to COVID-19 in Western SocietyDerek Raghavan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
New prognostic factors for stage I testicular cancer: but will they make it to broadway?Derek Raghavan
Journal of Oncology Practice|May 11, 2017
No Bridge Over Troubled Water: Slow Progress in Bladder CancerDerek Raghavan
European Urology|November 7, 2007
Re: Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot studyDerek Raghavan
Seminars in Oncology|December 17, 2013
Costs of cancer care: rhetoric, value, and steps forwardDerek Raghavan
Oncology (Williston Park, N.Y.)|March 1, 2014
In germ cell cancer, are we at the end of the chemotherapy era? No-targeted therapies have not heralded its demiseDerek Raghavan
Oncology (Williston Park, N.Y.)|August 28, 2013
Remembering old lessons in prostate cancer: avoiding errors 'in PARPituity'Derek Raghavan
Oncology (Williston Park, N.Y.)|January 17, 2015
Big data: not really the same as level 1 dataDerek Raghavan Fasco
JCO Oncology Practice|November 12, 2024
Dealing With the Gene BluesJohn Burke, Derek Raghavan
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|December 31, 2015
Predicting Low Trial Accrual Mathematically: Is That the Right Emphasis?Derek Raghavan
JCO Oncology Practice|February 10, 2021
Arrogance or Stupidity? Unsuccessful Approaches to COVID-19 in Western SocietyDerek Raghavan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
New prognostic factors for stage I testicular cancer: but will they make it to broadway?Derek Raghavan
Journal of Oncology Practice|May 11, 2017
No Bridge Over Troubled Water: Slow Progress in Bladder CancerDerek Raghavan
European Urology|November 7, 2007
Re: Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot studyDerek Raghavan
Seminars in Oncology|December 17, 2013
Costs of cancer care: rhetoric, value, and steps forwardDerek Raghavan
Oncology (Williston Park, N.Y.)|March 1, 2014
In germ cell cancer, are we at the end of the chemotherapy era? No-targeted therapies have not heralded its demiseDerek Raghavan
Oncology (Williston Park, N.Y.)|August 28, 2013
Remembering old lessons in prostate cancer: avoiding errors 'in PARPituity'Derek Raghavan
Oncology (Williston Park, N.Y.)|January 17, 2015
Big data: not really the same as level 1 dataDerek Raghavan Fasco
JCO Oncology Practice|November 12, 2024
Dealing With the Gene BluesJohn Burke, Derek Raghavan
Pageof 13